Antioxidant and Anticholinesterase Potentials of Novel 4,6-Dimethoxyindole based Unsymmetrical Azines: Synthesis, Molecular Modeling, In Silico ADME Prediction and Biological Evaluations

References

• S. S. Chourasiya, D. Kathuria, S. Singh, V. C. Sonawane, A. K. Chakraborti, and P. V. Bharatam, “Design, Synthesis and Biological Evaluation of Novel Unsymmetrical Azines as Quorum Sensing Inhibitors,” RSC Advances 5, no. 97 (2015): 80027–38. doi:10.1039/C5RA12925G
   Web of Science ®Google Scholar
• S. Bondock, H. Gieman, and A. El-Shafei, “Selective Synthesis, Structural Studies and Antitumor Evaluation of Some Novel Unsymmetrical 1-Hetaryl-4-(2-Chloroquinolin-3-Yl)Azines,” Journal of Saudi Chemical Society 20, no. 6 (2016): 695–702. doi:10.1016/j.jscs.2015.01.005
   Web of Science ®Google Scholar
• J. Safari, and S. Gandomi-Ravandi, “Structure, Synthesis and Application of Azines: A Historical Perspective,” RSC Advances. 4, no. 86 (2014): 46224–49. doi:10.1039/C4RA04870A
   Web of Science ®Google Scholar
• C. Chiter, A. Bouchama, T. N. Mouas, H. Allal, M. Yahiaoui, I. Warad, A. Zarrouk, and A. Djedouani, “Synthesis, Crystal Structure, Spectroscopic and Hirshfeld Surface Analysis, NCI-RDG, DFT Computations and Antibacterial Activity of New Asymmetrical Azines,” Journal of Molecular Structure. 1217 (2020): 128376. doi:10.1016/j.molstruc.2020.128376
   Web of Science ®Google Scholar
• Y. Sun, J.-H. Hu, J. Qi, and J.-B. Li, “A Highly Selective Colorimetric and “Turn-on” Fluorimetric Chemosensor for Detecting CN− Based on Unsymmetrical Azine Derivatives in Aqueous Media,” Spectrochimica Acta Part A 167 (2016): 101–5. doi:10.1016/j.saa.2016.05.017
   PubMed Web of Science ®Google Scholar
• V. B. Kurteva, S. P. Simeonov, and M. Stoilova-Disheva, “Symmetrical Acyclic Aryl Aldazines with Antibacterial and Antifungal Activity,” Pharmacology & Pharmacy 02, no. 01 (2011): 1–9. doi:10.4236/pp.2011.21001
   Google Scholar
• J. Lasri, M. M. Aly, N. E. Eltayeb, and B. A. Babgi, “Synthesis of Symmetrical and Asymmetrical Azines from Hydrazones and/or Ferrocenecarboxaldehyde as Potential Antimicrobial–Antitumor Agents,” Journal of Molecular Structure. 1164 (2018): 1–8. doi:10.1016/j.molstruc.2018.03.030
   Web of Science ®Google Scholar
• H. Suleyman, H. I. Gul, and M. Asoglu, “Anti-İnflammatory Activity of 3-Benzoyl-1-Methyl-4-Phenyl-4-Piperidinol Hydrochloride,” Pharmacological Research 47, no. 6 (2003): 471–5. doi:10.1016/S1043-6618(03)00015-X
   PubMed Web of Science ®Google Scholar
• C. Liang, J. Xia, D. Lei, X. Li, Q. Yao, and J. Gao, “Synthesis, in Vitro and in Vivo Antitumor Activity of Symmetrical bis-Schiff Base Derivatives of İsatin,” European Journal of Medicinal Chemistry 74 (2014): 742–50. doi:10.1016/j.ejmech.2013.04.040
   PubMed Web of Science ®Google Scholar
• J. Easmon, G. Pürstinger, G. Heinisch, T. Roth, H. H. Fiebig, W. Holzer, W. Jäger, M. Jenny, and J. Hofmann, “Synthesis, Cytotoxicity, and Antitumor Activity of Copper(II) and İron(II) Complexes of 4N-Azabicyclo[3.2.2]Nonane Thiosemicarbazones Derived from Acyl Diazines,” Journal of Medicinal Chemistry 44, no. 13 (2001): 2164–71. doi:10.1021/jm000979z
   PubMed Web of Science ®Google Scholar
• W. J. Stratton, “Metal Complexes with Azine Ligands. II. Iron(II), Cobalt(II), and Nickel(II) Complexes with 2-Pyridyl Methyl Ketazine,” Inorganic Chemistry 9, no. 3 (1970): 517–20. doi:10.1021/ic50085a017
   Web of Science ®Google Scholar
• A. Garg, and J. P. Tandon, “Coordination Behaviour of Azines towards İron(II), Palladium(II) and Platinum(II),” Transition Metal Chemistry 13, no. 5 (1988): 395–7. doi:10.1007/BF01225136
   Web of Science ®Google Scholar
• D. Palanimuthu, R. Poon, S. Sahni, R. Anjum, D. Hibbs, H.-Y. Lin, P. V. Bernhardt, D. S. Kalinowski, and D. R. Richardson, “A Novel Class of Thiosemicarbazones Show Multi-Functional Activity for the Treatment of Alzheimer’s Disease,” European Journal of Medicinal Chemistry. 139 (2017): 612–32. doi:10.1016/j.ejmech.2017.08.021
   PubMed Web of Science ®Google Scholar
• Muhammad Yar, Marek Bajda, Rana Mehmood, Lala Sidra, Nisar Ullah, Lubna Shahzadi, Muhammad Ashraf, Tayaba Ismail, Sohail Shahzad, Zulfiqar Khan, et al, “Design and Synthesis of New Dual Binding Site Cholinesterase İnhibitors: İn Vitro İnhibition Studies with in Silico Docking,” Letters in Drug Design & Discovery 11, no. 3 (2014): 331–8. doi:10.2174/15701808113106660078
   PubMed Web of Science ®Google Scholar
• Carolina S. Passos, Claudia A. Simões-Pires, Alessandra Nurisso, Tatiane C. Soldi, Lucilia Kato, Cecilia M. A. de Oliveira, Emiret O. de Faria, Laurence Marcourt, Carmem Gottfried, Pierre-Alain Carrupt, et al, “Indole Alkaloids of Psychotria ∼ as Multifunctional Cholinesterases and Monoamine Oxidases İnhibitors,” Phytochemistry 86 (2013): 8–20. doi:10.1016/j.phytochem.2012.11.015
   PubMed Web of Science ®Google Scholar
• Pilar Muñoz-Ruiz, Laura Rubio, Esther García-Palomero, Isabel Dorronsoro, María del Monte-Millán, Rita Valenzuela, Paola Usán, Celia de Austria, Manuela Bartolini, Vincenza Andrisano, et al, “Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: new Disease-Modifying Agents for Alzheimer’s Disease,” Journal of Medicinal Chemistry 48, no. 23 (2005): 7223–33. doi:10.1021/jm0503289
   PubMed Web of Science ®Google Scholar
• Gerda Brunhofer, Adyary Fallarero, Daniela Karlsson, Ana Batista-Gonzalez, Pravin Shinde, C. Gopi Mohan, and Pia Vuorela, “Exploration of Natural Compounds as Sources of New Bifunctional Scaffolds Targeting Cholinesterases and Beta Amyloid Aggregation: The Case of Chelerythrine,” Bioorganic and Medicinal Chemistry. 20, no. 22 (2012): 6669–79. doi:10.1016/j.bmc.2012.09.040
   PubMed Web of Science ®Google Scholar
• Milenko N. Ristić, Niko S. Radulović, Biljana R. Dekić, Vidoslav S. Dekić, Novica R. Ristić, and Zorica Stojanović-Radić, “Synthesis and Spectral Characterization of Asymmetric Azines Containing a Coumarin Moiety: The Discovery of New Antimicrobial and Antioxidant Agents,” Chemistry & Biodiversity 16, no. 1 (2019): e1800486. doi:10.1002/cbdv.201800486
   PubMed Web of Science ®Google Scholar
• W. S. Hamama, M. A. Gouda, H. A. Kamal El-Din, and H. H. Zoorob, “Highlights on the Synthesis of Novel Phenothiazine-Based Azines Scaffold as Antioxidant Agents,” Journal of Heterocyclic Chemistry 57, no. 1 (2020): 257–67. doi:10.1002/jhet.3771
   Web of Science ®Google Scholar
• T. Yamamura, K. Suzuki, T. Yamaguchi, and T. Nishiyama, “Antioxidant Activities of Phenothiazines and Related Compounds: Correlation between the Antioxidant Activities and Dissociation Energies of O–H or N–H Bonds,” Bulletin of the Chemical Society of Japan 70, no. 2 (1997): 413–9. doi:10.1246/bcsj.70.413
   Web of Science ®Google Scholar
• E. R. Radwanski, and R. L. Last, “Tryptophan Biosynthesis and Metabolism: biochemical and Molecular Genetics,” Plant Cell. 7 (1995): 921–34. doi:10.1105/tpc.7.7.921
   PubMed Web of Science ®Google Scholar
• I. P. Kema, E. G. de Vries, and F. A. Muskiet, “Clinical Chemistry of Serotonin and Metabolites,” Journal of Chromatography B: Biomedical Sciences and Applications 747, no. 1-2 (2000): 33–48. doi:10.1016/S0378-4347(00)00341-8
   PubMedGoogle Scholar
• R. McDanell, A. E. M. McLean, A. B. Hanley, R. K. Heaney, and G. R. Fenwick, “Chemical and Biological Properties of İndole Glucosinolates (Glucobrassicins): a Review,” Food Chemistry. 26, no. 1 (1988): 59–70. doi:10.1016/0278-6915(88)90042-7
   Google Scholar
• B. B. Aggarwal, and H. Ichikawa, `“`Molecular Targets and Anticancer Potential of İndole-3-Carbinol and İts Derivatives,” Cell Cycle 4, no. 9 (2005): 1201–15. doi:10.4161/cc.4.9.1993
   PubMed Web of Science ®Google Scholar
• V. Sharma, P. Kumar, and D. Pathak, “Biological Importance of the Indole Nucleus in Recent Years: A Comprehensive Review,” Journal of Heterocyclic Chemistry. 47 (2010): 491–502. doi:10.1002/jhet.349
   Web of Science ®Google Scholar
• A. Ahmad, W. A. Sakr, and K. M. Wahidur Rahman, “Anticancer Properties of İndole Compounds: mechanism of Apoptosis İnduction and Role in Chemotherapy,” Current Drug Targets 11, no. 6 (2010): 652–66. doi:10.2174/138945010791170923
   PubMed Web of Science ®Google Scholar
• M. F. Saglam, M. Bingul, E. Şenkuytu, M. Boga, Y. Zorlu, H. Kandemir, and I. F. Sengul, “Synthesis, Characterization, UV–Vis Absorption and Cholinesterase İnhibition Properties of Bis-İndolyl İmine Ligand Systems,” Journal of Molecular Structure. 1215 (2020): 128308. doi:10.1016/j.molstruc.2020.128308
   Web of Science ®Google Scholar
• E. Şenkuytu, M. Bingul, M. F. Saglam, H. Kandemir, and I. F. Sengul, “Synthesis of a Novel N,N',N'-Tetraacetyl-4,6-Dimethoxyindole-Based Dual Chemosensor for the Recognition of Fe3+ and Cu2+ İons,” Inorganica Chimica Acta 495 (2019): 118947. doi:10.1016/j.ica.2019.05.046
   Web of Science ®Google Scholar
• M. Bingul, S. Ercan, and M. Boga, “The Design of Novel 4,6-Dimethoxyindole Based Hydrazide-Hydrazones: Molecular Modeling, Synthesis and Anticholinesterase Activity,” Journal of Molecular Structure. 1213 (2020): 128202. doi:10.1016/j.molstruc.2020.128202
   Web of Science ®Google Scholar
• M. Bingul, “Synthesis and Characterisation of Novel 4,6-Dimethoxyindole-7- and -2-Thiosemicarbazone Derivatives: Biological Evaluation as Antioxidant and Anticholinesterase Candidates,” Journal of Chemical Research 43, no. 9–10 (2019): 399–406. doi:10.1177/1747519819868386
   Web of Science ®Google Scholar
• M. Bingul, M. F. Saglam, H. Kandemir, M. Boga, and I. F. Sengul, “Synthesis of İndole-2-Carbohydrazides and 2-(İndol-2-Yl)-1,3,4-Oxadiazoles as Antioxidants and Their Acetylcholinesterase İnhibition Properties,” Monatshefte für Chemie 150, no. 8 (2019): 1553–60. doi:10.1007/s00706-019-02462-y
   Web of Science ®Google Scholar
• A. Mollica, R. Costante, A. Akdemir, S. Carradori, A. Stefanucci, G. Macedonio, M. Ceruso, and C. T. Supuran, “Exploring New Probenecid-Based Carbonic Anhydrase İnhibitors: Synthesis, Biological Evaluation and Docking Studies,” Bioorganic & Medicinal Chemistry 23, no. 17 (2015): 5311–8. doi:10.1016/j.bmc.2015.07.066
   PubMed Web of Science ®Google Scholar
• M. Bingul, B. B. Cheung, N. Kumar, and D. S. Black, “Synthesis of Symmetrical and Unsymmetrical Diindolylmethanes via Acid-Catalysed Electrophilic Substitution Reactions,” Tetrahedron 70, no. 40 (2014): 7363–9. doi:10.1016/j.tet.2014.06.087
   Web of Science ®Google Scholar
• M. S. Blois, “Antioxidant Determinations by the Use of a Stable Free Radical,” Nature 181, no. 4617 (1958): 1199–200. doi:10.1038/1811199a0
   Web of Science ®Google Scholar
• N. J. Miller, C. Rice-Evans, and M. J. Davies, “A New Method for Measuring Antioxidant Activity,” Biochemical Society Transactions 21, no. 2 (1993): 95S. doi:10.1042/bst021095s
   PubMedGoogle Scholar
• R. Apak, K. Güçlü, M. Özyürek, S. E. N. Karademir, and M. Altun, “Total Antioxidant Capacity Assay of Human Serum Using Copper(II)-Neocuproine as Chromogenic Oxidant: The CUPRAC Method,” Free Radical Research 39, no. 9 (2005): 949–961. doi:10.1080/10715760500210145
   PubMed Web of Science ®Google Scholar
• G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, “A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity,” Biochemical Pharmacology. 7, no. 2 (1961): 88–95. doi:10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• J. Cheung, M. J. Rudolph, F. Burshteyn, M. S. Cassidy, E. N. Gary, J. Love, M. C. Franklin, and J. J. Height, “Structures of Human Acetylcholinesterase in Complex with Pharmacologically İmportant Ligands,” Journal of Medicinal Chemistry 55, no. 22 (2012): 10282–10286. doi:10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• A. Meden, D. Knez, M. Jukic, M. X. Brazzolotto, M. Grsic, A. Pislar, A. Zahirovic, J. Kos, F. Nachon, J. Svete, et al, “Tryptophan-Derived Butyrylcholinesterase İnhibitors as Promising Leads against Alzheimer’s Disease,” Chemical Communications 55, no. 26 (2019): 3765–3768. doi:10.1039/C9CC01330J
   PubMed Web of Science ®Google Scholar
• F. Y. Dupradeau, A. Pigache, T. Zaffran, C. Savineau, R. Lelong, N. Grivel, D. Lelong, W. Rosanski, and P. Cieplak, “The R.E.D. tools: Advances in RESP and ESP Charge Derivation and Force Field Library Building,” Physical Chemistry Chemical Physics 12, no. 28 (2010): 7821–7839. doi:10.1039/c0cp00111b
   PubMed Web of Science ®Google Scholar
• F. Wang, J. P. Becker, P. Cieplak, and F. Y. Dupradeau, “R.E.D. Python: Object Oriented Programming for Amber Force Fields,” Université de Picardie – Jules Verne, Sanford Burnham Prebys Medical Discovery Institute, Nov. 2013.
   Google Scholar
• S. Ercan, “Docking and Molecular Dynamics Calculations of Some Previously Studied and Newly Designed Ligands to Catalytic Core Domain of HIV-1 Integrase and an Investigation to Effects of Conformational Changes of Protein on Docking Results,” Journal of the Turkish Chemical Society, Section A 4, no. 1 (2016): 243–243. doi:10.18596/jotcsa.287327
   Google Scholar
• M. Bingul, N. Kumar, and D. S. Black, “Synthesis and Reactions of New 2-Hydroxymethyldimethoxyindoles,” Tetrahedron 72, no. 1 (2016): 234–9. doi:10.1016/j.tet.2015.11.038
   Web of Science ®Google Scholar
• A. M. McDonnell, and C. H. Dang, “Basic Review of the Cytochrome p450 System,” Journal of the Advanced Practitioner in Oncology 4, no. 4 (2013): 263–8. doi:10.6004/jadpro.2013.4.4.7
   PubMedGoogle Scholar
• Z. Bibi, “Role of Cytochrome P450 in Drug İnteractions,” Nutrition & Metabolism 5, no. 1 (2008): 27. doi:10.1186/1743-7075-5-27
   PubMedGoogle Scholar